![Gary Patou](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gary Patou
Direktor/Vorstandsmitglied bei
XENON PHARMACEUTICALS INC.
Vermögen: 2 Mio $ am 31.07.2026
Profil
Gary Patou currently serves as Independent Director at Xenon Pharmaceuticals, Inc. since 2004, Chief Medical Officer at Star Therapeutics, Inc. since 2020, and Advisor at Scleroderma Research Foundation since 2021.
Former roles include President & Chief Executive Officer at Cerimon Pharmaceuticals, Inc. from 2008 to 2009; Director at Ligand UK Ltd. in 1995; Senior VP, Director-Project & Portfolio Management at GSK Plc and Smithkline Beecham Pharmaceuticals Ltd. from 1995 to 2000; Director & Chief Medical Officer at Biointervene, Inc.; Chief Medical Officer & Executive Vice President at Oscient Pharmaceuticals Corp.
from 2004 to 2005; President at Genesoft Pharmaceuticals, Inc. in 2004; Chief Medical Officer at Peplin Ltd. in 2007; Chief Medical Officer at Cerimon Pharmaceuticals, Inc. from 2005 to 2006; Senior Medical Advisor at Chiasma, Inc. from 2014 to 2020; Advisor at MPM BioImpact LLC from 2020 to 2022; Chief Medical Officer at Pacira Biosciences, Inc. from 2009 to 2015; Chief Medical Officer at True North Therapeutics, Inc. from 2016 to 2017; and Chief Medical Officer at Blade Therapeutics, Inc. from 2018 to 2020.
Education includes undergraduate, graduate, and doctorate degrees from the University of London.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 05.06.2026 | 34’689 ( 0.04% ) | 2 Mio $ | 31.07.2026 |
Aktive Positionen von Gary Patou
| Unternehmen | Position | Beginn |
|---|---|---|
| XENON PHARMACEUTICALS INC. | Direktor/Vorstandsmitglied | 01.01.2004 |
Star Therapeutics, Inc.
 Star Therapeutics, Inc. BiotechnologyHealth Technology Develops antibody therapies for hematology and immunology problems | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2020 |
Scleroderma Research Foundation
 Scleroderma Research Foundation BiotechnologyHealth Technology Engages in medical research to discover treatments for scleroderma | Berater | 01.01.2021 |
Ehemalige bekannte Positionen von Gary Patou
| Unternehmen | Position | Ende |
|---|---|---|
MPM BioImpact LLC
 MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Berater | 30.07.2022 |
| CHIASMA, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2020 |
Blade Therapeutics, Inc.
 Blade Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focuses on developing treatments for fibrotic and neurodegenerative diseases | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2020 |
True North Therapeutics, Inc.
 True North Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies that selectively inhibit the complement system to treat rare diseases | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2017 |
| PACIRA BIOSCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 19.08.2015 |
Ausbildung von Gary Patou
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
70
Beziehungen ersten Grades
17
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 17 |
|---|---|
Oscient Pharmaceuticals Corp.
 Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Markets and sells products to community-based primary care physicians | Commercial Services |
Ligand UK Ltd.
 Ligand UK Ltd. BiotechnologyHealth Technology Engages in research and development & sells pharmaceutical products | Health Technology |
Genesoft Pharmaceuticals, Inc.
 Genesoft Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and develops anti-infective products | Commercial Services |
Peplin Ltd.
 Peplin Ltd. Pharmaceuticals: OtherHealth Technology Develops human therapeutic products for the treatment of cancer | Health Technology |
Cerimon Pharmaceuticals, Inc.
 Cerimon Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops and distributes biopharmaceutical products | Health Technology |
Chiasma, Inc.
 Chiasma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops treatments for rare and serious chronic disease | Health Technology |
MPM BioImpact LLC
MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Finance |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Pacira Biosciences, Inc.
 Pacira Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures injectable therapeutic products | Health Technology |
Xenon Pharmaceuticals, Inc.
 Xenon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and delivering of therapeutics for neurological & psychiatric disorders | Health Technology |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Scleroderma Research Foundation
Scleroderma Research Foundation BiotechnologyHealth Technology Engages in medical research to discover treatments for scleroderma | Health Technology |
Smithkline Beecham Pharmaceuticals Ltd. | |
True North Therapeutics, Inc.
True North Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies that selectively inhibit the complement system to treat rare diseases | Health Technology |
Blade Therapeutics, Inc.
Blade Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focuses on developing treatments for fibrotic and neurodegenerative diseases | Health Technology |
Biointervene, Inc.
 Biointervene, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Star Therapeutics, Inc.
Star Therapeutics, Inc. BiotechnologyHealth Technology Develops antibody therapies for hematology and immunology problems | Health Technology |
